Literature DB >> 20512936

TRAF6 is autoinhibited by an intramolecular interaction which is counteracted by trans-ubiquitination.

Kent Z Q Wang1, Deborah L Galson, Philip E Auron.   

Abstract

The tumor necrosis factor (TNF) receptor associated factor (TRAF) class of intracellular signal transducers is responsible for mediating many of the activation events initiated by TNF receptor (TNFR) and Toll-like/Interleukin-1, -17, and -18 receptor (TIR) families. Investigation of the mechanism by which TRAF6 is activated has demonstrated that two critical domains of the molecule required for activation and downstream signaling are involved in an interaction which renders the molecule inactive and structurally closed, as well as incapable of auto-ubiquitination. Contrary to its assumed role as a direct mediator of protein-protein interaction, TRAF auto-ubiquitination is a means of sustaining an open conformation active in downstream signaling. Furthermore, the inferred cis-function of TRAF auto-ubiquitination is now demonstrated to act in trans and requires both the RING-Zinc (RZ) fingers region and coiled-coil domain. We also observed that both the RZ fingers region and the MATH domain are targets for ubiquitination. Although TRAF6 ubiquitination has emerged as a hallmark of activation, trans-ubiquitination induced by two TRAF6 muteins is insufficient for NF-kappaB activation. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512936      PMCID: PMC3407548          DOI: 10.1002/jcb.22589

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  30 in total

1.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction.

Authors:  Y C Park; H Ye; C Hsia; D Segal; R L Rich; H C Liou; D G Myszka; H Wu
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

3.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK.

Authors:  C Wang; L Deng; M Hong; G R Akkaraju; J Inoue ; Z J Chen
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

Review 4.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

Review 5.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

6.  Membrane localization of TRAF 3 enables JNK activation.

Authors:  H Dadgostar; G Cheng
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

7.  Ubiquitin activated tumor necrosis factor receptor associated factor-6 (TRAF6) is recycled via deubiquitination.

Authors:  Liselotte E Jensen; Alexander S Whitehead
Journal:  FEBS Lett       Date:  2003-10-09       Impact factor: 4.124

8.  Distinct molecular mechanism for initiating TRAF6 signalling.

Authors:  Hong Ye; Joseph R Arron; Betty Lamothe; Maurizio Cirilli; Takashi Kobayashi; Nirupama K Shevde; Deena Segal; Oki K Dzivenu; Masha Vologodskaia; Mijung Yim; Khoi Du; Sujay Singh; J Wesley Pike; Bryant G Darnay; Yongwon Choi; Hao Wu
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

9.  Molecular basis for CD40 signaling mediated by TRAF3.

Authors:  C Z Ni; K Welsh; E Leo; C K Chiou; H Wu; J C Reed; K R Ely
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 10.  All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.

Authors:  Jee Y Chung; Young Chul Park; Hong Ye; Hao Wu
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

View more
  12 in total

1.  Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-κB activation.

Authors:  Charilaos Megas; Eudoxia G Hatzivassiliou; Qian Yin; Elli Marinopoulou; Paul Hadweh; Dario A A Vignali; George Mosialos
Journal:  Cell Signal       Date:  2010-12-23       Impact factor: 4.315

2.  EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis.

Authors:  Haizhong Feng; Giselle Y Lopez; Chung Kwon Kim; Angel Alvarez; Christopher G Duncan; Ryo Nishikawa; Motoo Nagane; An-Jey A Su; Philip E Auron; Matthew L Hedberg; Lin Wang; Jeffery J Raizer; John A Kessler; Andrew T Parsa; Wei-Qiang Gao; Sung-Hak Kim; Mutsuko Minata; Ichiro Nakano; Jennifer R Grandis; Roger E McLendon; Darell D Bigner; Hui-Kuan Lin; Frank B Furnari; Webster K Cavenee; Bo Hu; Hai Yan; Shi-Yuan Cheng
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

3.  TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.

Authors:  Anguo Liu; Ping Gong; Sang W Hyun; Kent Z Q Wang; Elizabeth A Cates; Darren Perkins; Douglas D Bannerman; Adam C Puché; Vladimir Y Toshchakov; Shengyun Fang; Philip E Auron; Stefanie N Vogel; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

4.  TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.

Authors:  Sabrina Semmler; Myriam Gagné; Pranav Garg; Sarah R Pickles; Charlotte Baudouin; Emeline Hamon-Keromen; Laurie Destroismaisons; Yousra Khalfallah; Mathilde Chaineau; Elise Caron; Andrew N Bayne; Jean-François Trempe; Neil R Cashman; Alexandra T Star; Arsalan S Haqqani; Thomas M Durcan; Elizabeth M Meiering; Janice Robertson; Nathalie Grandvaux; Steven S Plotkin; Heidi M McBride; Christine Vande Velde
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

5.  TRAF6 expression is associated with poorer prognosis and high recurrence in urothelial bladder cancer.

Authors:  Hanli Wu; Aixia Hao; Honghong Cui; Wenbin Wu; Huanrong Yang; Baohong Hu; Peng Li
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

6.  Intermolecular binding between TIFA-FHA and TIFA-pT mediates tumor necrosis factor alpha stimulation and NF-κB activation.

Authors:  Chia-Chi Flora Huang; Jui-Hung Weng; Tong-You Wade Wei; Pei-Yu Gabriel Wu; Pang-Hung Hsu; Yu-Hou Chen; Shun-Chang Wang; Dongyan Qin; Chin-Chun Hung; Shui-Tsung Chen; Andrew H-J Wang; John Y-J Shyy; Ming-Daw Tsai
Journal:  Mol Cell Biol       Date:  2012-05-07       Impact factor: 4.272

7.  The ubiquitin-editing enzyme A20 regulates synapse remodeling and efficacy.

Authors:  Shaolin Mei; Hongyu Ruan; Qi Ma; Wei-Dong Yao
Journal:  Brain Res       Date:  2019-11-26       Impact factor: 3.610

8.  Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.

Authors:  Stefanie Ginster; Maureen Bardet; Adeline Unterreiner; Claire Malinverni; Florian Renner; Stephen Lam; Felix Freuler; Bertran Gerrits; Johannes Voshol; Thomas Calzascia; Catherine H Régnier; Martin Renatus; Rainer Nikolay; Laura Israël; Frédéric Bornancin
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

9.  Positive regulation of TRAF6-dependent innate immune responses by protein phosphatase PP1-γ.

Authors:  Amanda M Opaluch; Monika Schneider; Chih-yuan Chiang; Quy T Nguyen; Ana M Maestre; Lubbertus C F Mulder; Ismael Secundino; Paul D De Jesus; Renate König; Viviana Simon; Victor Nizet; Graham MacLeod; Susannah Varmuza; Ana Fernandez-Sesma; Sumit K Chanda
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

10.  Bid Promotes K63-Linked Polyubiquitination of Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) and Sensitizes to Mutant SOD1-Induced Proinflammatory Signaling in Microglia.

Authors:  Sinéad Kinsella; Hans-Georg König; Jochen H M Prehn
Journal:  eNeuro       Date:  2016-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.